Fellowship · Boston, MA
Sponsored by Beth Israel Deaconess Medical Center
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.
Neurology · 2021 · 575 citations · Pushpa Narayanaswami
Skeletal muscle in amyotrophic lateral sclerosis.
Brain : a journal of neurology · 2023 · 85 citations · Seward Rutkove
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.
mAbs · 2025 · 31 citations · Pushpa Narayanaswami
Utilization of MG-ADL in myasthenia gravis clinical research and care.
Muscle & nerve · 2022 · 94 citations · Nicholas Silvestri
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.
Frontiers in immunology · 2022 · 100 citations · Nicholas Silvestri
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
The Lancet. Neurology · 2024 · 49 citations · Pushpa Narayanaswami
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA neurology · 2021 · 118 citations · Courtney McIlduff, Seward Rutkove
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Neurology · 2022 · 61 citations · Nicholas Silvestri